Sustained cough in methotrexate therapy for rheumatoid arthritis

被引:20
作者
Schnabel, A
Dalhoff, K
Bauerfeind, S
Barth, J
Gross, WL
机构
[1] Med. Universität Lübeck, Rheumatologische Poliklinik, Rheumaklinik Bad Bramstedt
[2] Christian-Albrechts-Universität, I. Medizinische Abteilung
[3] Rheumaklinik Bad Bramstedt
关键词
rheumatoid arthritis; methotrexate; lung; side effects;
D O I
10.1007/BF02229707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sustained cough is a frequent complaint in methotrexate (MTX) treatment for rheumatoid arthritis and can be a symptom of incipient MTX-induced pneumonitis. This study was performed to characterize MTX-associated cough clinically and to clarify by which means this condition can be distinguished from incipient MTX pneumonitis. Three patients with MTX-induced pneumonitis and 10 patients with sustained cough unassociated with pneumonitis were examined clinically, by pulmonary function testing, and bronchoalveolar lavage (BAL). In MTX pneumonitis, cough was associated with progressive dyspnoea, constitutional symptoms, impaired pulmonary function, and interstitial infiltration of variable degree by chest X-ray. BAL cytology invariably showed lymphocytic alveolitis while transbronchial biopsy revealed active interstitial inflammation in only one patient. Ten patients had sustained, nonprogressive cough in the absence of constitutional symptoms, progressive dyspnoea and impaired pulmonary function. Neither X-ray nor BAL nor transbronchial biopsy revealed any evidence of interstitial lung disease. In the majority of these patients, cough abated with symptomatic treatment with or without temporary discontinuation of MTX. It is concluded that MTX-associated cough can be a reflection of isolated airway disease. Clinically, absence of constitutional symptoms, impaired pulmonary function, and interstitial infiltration on X-ray distinguished this condition from incipient MTX pneumonitis. Cough without pulmonary parenchymal involvement appears to result from an irritant effect of MTX on the airways.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 26 条
[1]   LEUKOCYTE MIGRATION-INHIBITION IN METHOTREXATE-INDUCED PNEUMONITIS - EVIDENCE FOR AN IMMUNOLOGICAL CELL-MEDIATED MECHANISM [J].
AKOUN, GM ;
GAUTHIERRAHMAN, S ;
MAYAUD, CM ;
TOUBOUL, JL ;
DENIS, MF .
CHEST, 1987, 91 (01) :96-99
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   METHOTREXATE-RELATED PULMONARY COMPLICATIONS IN RHEUMATOID-ARTHRITIS [J].
BARRERA, P ;
LAAN, RFJM ;
VANRIEL, PLCM ;
DEKHUIJZEN, PNR ;
BOERBOOMS, AMT ;
VANDEPUTTE, LBA .
ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (07) :434-439
[4]   ACUTE LUNG-DISEASE ASSOCIATED WITH LOW-DOSE PULSE METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CANNON, GW ;
WARD, JR ;
CLEGG, DO ;
SAMUELSON, CO ;
ABBOTT, TM .
ARTHRITIS AND RHEUMATISM, 1983, 26 (10) :1269-1274
[5]  
CARROLL GJ, 1994, J RHEUMATOL, V21, P51
[6]   PULMONARY-DISEASE DURING THE TREATMENT OF RHEUMATOID-ARTHRITIS WITH LOW-DOSE PULSE METHOTREXATE [J].
CARSON, CW ;
CANNON, GW ;
EGGER, MJ ;
WARD, JR ;
CLEGG, DO .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1987, 16 (03) :186-195
[7]   SUCCESSFUL REINTRODUCTION OF METHOTREXATE AFTER PNEUMONITIS IN 2 PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
COOK, NJ ;
CARROLL, GJ .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (02) :272-274
[8]   DIAGNOSIS BY BRONCHOALVEOLAR LAVAGE OF CAUSE OF PULMONARY-INFILTRATES IN HEMATOLOGICAL MALIGNANCIES [J].
COSTABEL, U ;
BROSS, KJ ;
MATTHYS, H .
BRITISH MEDICAL JOURNAL, 1985, 290 (6474) :1041-1041
[9]   METHOTREXATE PNEUMONITIS AFTER LOW-DOSE THERAPY FOR RHEUMATOID-ARTHRITIS [J].
ENGELBRECHT, JA ;
CALHOON, SL ;
SCHERRER, JJ .
ARTHRITIS AND RHEUMATISM, 1983, 26 (10) :1275-1278
[10]  
FEHLAUER CS, 1989, J RHEUMATOL, V16, P307